Clinical Trial Update: Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy [NA]

View source ↗

Summary

This completed clinical trial compares subconjunctival versus topical bevacizumab as adjunct therapy to trabeculectomy for glaucoma outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sudhalkar Eye Hospital | Conditions: Complications of Treatment, Progression | NA | Status: COMPLETED